vs

Side-by-side financial comparison of INDEPENDENCE REALTY TRUST, INC. (IRT) and Kiniksa Pharmaceuticals International, plc (KNSA). Click either name above to swap in a different company.

Kiniksa Pharmaceuticals International, plc is the larger business by last-quarter revenue ($202.1M vs $165.3M, roughly 1.2× INDEPENDENCE REALTY TRUST, INC.). On growth, Kiniksa Pharmaceuticals International, plc posted the faster year-over-year revenue change (65.0% vs 2.5%). Over the past eight quarters, Kiniksa Pharmaceuticals International, plc's revenue compounded faster (59.1% CAGR vs 2.2%).

Brandywine Realty Trust is a Philadelphia-based real estate investment trust (REIT) that invests in office buildings in Philadelphia, Washington, D.C., and Austin, Texas.

Kiniksa Pharmaceuticals International plc is a global biopharmaceutical firm focused on discovering, developing and commercializing targeted therapies for patients with unmet medical needs, primarily in autoimmune, inflammatory and rare disease segments. It operates across major markets including North America, Europe and Asia, advancing a pipeline of clinical-stage and approved treatment candidates.

IRT vs KNSA — Head-to-Head

Bigger by revenue
KNSA
KNSA
1.2× larger
KNSA
$202.1M
$165.3M
IRT
Growing faster (revenue YoY)
KNSA
KNSA
+62.4% gap
KNSA
65.0%
2.5%
IRT
Faster 2-yr revenue CAGR
KNSA
KNSA
Annualised
KNSA
59.1%
2.2%
IRT

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
IRT
IRT
KNSA
KNSA
Revenue
$165.3M
$202.1M
Net Profit
$14.2M
Gross Margin
89.6%
Operating Margin
9.8%
Net Margin
7.0%
Revenue YoY
2.5%
65.0%
Net Profit YoY
259.8%
EPS (diluted)
$0.00
$0.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IRT
IRT
KNSA
KNSA
Q1 26
$165.3M
Q4 25
$167.1M
$202.1M
Q3 25
$167.1M
$180.9M
Q2 25
$162.2M
$156.8M
Q1 25
$161.2M
$137.8M
Q4 24
$161.0M
$122.5M
Q3 24
$160.1M
$112.2M
Q2 24
$158.4M
$108.6M
Net Profit
IRT
IRT
KNSA
KNSA
Q1 26
Q4 25
$33.3M
$14.2M
Q3 25
$6.9M
$18.4M
Q2 25
$8.0M
$17.8M
Q1 25
$8.4M
$8.5M
Q4 24
$-1.0M
$-8.9M
Q3 24
$12.4M
$-12.7M
Q2 24
$10.4M
$-3.9M
Gross Margin
IRT
IRT
KNSA
KNSA
Q1 26
Q4 25
89.6%
Q3 25
88.8%
Q2 25
88.1%
Q1 25
87.0%
Q4 24
85.4%
Q3 24
82.1%
Q2 24
88.7%
Operating Margin
IRT
IRT
KNSA
KNSA
Q1 26
Q4 25
9.8%
Q3 25
13.3%
Q2 25
12.9%
Q1 25
9.6%
Q4 24
-15.7%
Q3 24
-8.6%
Q2 24
-0.1%
Net Margin
IRT
IRT
KNSA
KNSA
Q1 26
Q4 25
19.9%
7.0%
Q3 25
4.1%
10.2%
Q2 25
5.0%
11.4%
Q1 25
5.2%
6.2%
Q4 24
-0.6%
-7.3%
Q3 24
7.7%
-11.3%
Q2 24
6.5%
-3.6%
EPS (diluted)
IRT
IRT
KNSA
KNSA
Q1 26
$0.00
Q4 25
$0.14
$0.18
Q3 25
$0.03
$0.23
Q2 25
$0.03
$0.23
Q1 25
$0.04
$0.11
Q4 24
$-0.01
$-0.11
Q3 24
$0.05
$-0.18
Q2 24
$0.05
$-0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IRT
IRT
KNSA
KNSA
Cash + ST InvestmentsLiquidity on hand
$23.3M
$414.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$3.4B
$567.6M
Total Assets
$6.1B
$763.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IRT
IRT
KNSA
KNSA
Q1 26
$23.3M
Q4 25
$23.6M
$414.1M
Q3 25
$23.3M
$352.1M
Q2 25
$19.5M
$307.8M
Q1 25
$29.1M
$268.3M
Q4 24
$21.2M
$243.6M
Q3 24
$17.6M
$223.8M
Q2 24
$21.0M
$218.8M
Total Debt
IRT
IRT
KNSA
KNSA
Q1 26
Q4 25
$2.3B
Q3 25
$2.3B
Q2 25
$2.2B
Q1 25
$2.3B
Q4 24
$2.3B
Q3 24
$2.3B
Q2 24
$2.3B
Stockholders' Equity
IRT
IRT
KNSA
KNSA
Q1 26
$3.4B
Q4 25
$3.5B
$567.6M
Q3 25
$3.5B
$535.4M
Q2 25
$3.4B
$495.0M
Q1 25
$3.5B
$457.5M
Q4 24
$3.4B
$438.4M
Q3 24
$3.4B
$437.0M
Q2 24
$3.4B
$435.1M
Total Assets
IRT
IRT
KNSA
KNSA
Q1 26
$6.1B
Q4 25
$6.0B
$763.6M
Q3 25
$6.1B
$712.3M
Q2 25
$6.0B
$661.1M
Q1 25
$6.0B
$599.3M
Q4 24
$6.1B
$580.6M
Q3 24
$5.9B
$555.3M
Q2 24
$5.9B
$542.4M
Debt / Equity
IRT
IRT
KNSA
KNSA
Q1 26
Q4 25
0.66×
Q3 25
0.66×
Q2 25
0.66×
Q1 25
0.65×
Q4 24
0.68×
Q3 24
0.68×
Q2 24
0.66×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IRT
IRT
KNSA
KNSA
Operating Cash FlowLast quarter
$53.9M
Free Cash FlowOCF − Capex
$53.3M
FCF MarginFCF / Revenue
26.4%
Capex IntensityCapex / Revenue
0.3%
Cash ConversionOCF / Net Profit
3.80×
TTM Free Cash FlowTrailing 4 quarters
$136.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IRT
IRT
KNSA
KNSA
Q1 26
Q4 25
$282.1M
$53.9M
Q3 25
$79.3M
$33.7M
Q2 25
$82.2M
$28.1M
Q1 25
$60.4M
$22.3M
Q4 24
$259.8M
$18.8M
Q3 24
$69.2M
$-2.2M
Q2 24
$83.0M
$5.2M
Free Cash Flow
IRT
IRT
KNSA
KNSA
Q1 26
Q4 25
$53.3M
Q3 25
$33.0M
Q2 25
$27.9M
Q1 25
$22.2M
Q4 24
$18.6M
Q3 24
Q2 24
FCF Margin
IRT
IRT
KNSA
KNSA
Q1 26
Q4 25
26.4%
Q3 25
18.2%
Q2 25
17.8%
Q1 25
16.1%
Q4 24
15.2%
Q3 24
Q2 24
Capex Intensity
IRT
IRT
KNSA
KNSA
Q1 26
Q4 25
0.3%
Q3 25
0.4%
Q2 25
0.1%
Q1 25
0.1%
Q4 24
0.2%
Q3 24
0.0%
Q2 24
0.0%
Cash Conversion
IRT
IRT
KNSA
KNSA
Q1 26
Q4 25
8.48×
3.80×
Q3 25
11.51×
1.83×
Q2 25
10.22×
1.58×
Q1 25
7.23×
2.61×
Q4 24
Q3 24
5.60×
Q2 24
8.02×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IRT
IRT

Rental and other property revenue$165.2M100%
Other revenue$109.0K0%

KNSA
KNSA

Segment breakdown not available.

Related Comparisons